Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-05-11

Clinical Trial Update: A Phase II Trial of Salvage Treatment With Gemcitabine and S-1 Combination in Patients With Heavily Treated Advanced Colorectal Cancer. [Phase 2]

View source ↗

Summary

This entry notes a completed Phase II trial assessing salvage therapy with gemcitabine plus S-1 in heavily treated advanced colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: COMPLETED